This month’s Journal of Drugs in Dermatology issue is packed with groundbreaking studies and real-world insights spanning across age groups, skin types, and therapeutic categories. From improving dermatoporosis in older adults to exploring an acne management algorithm that smartly integrates acneceuticals, the April Editor’s Picks reflect dermatology’s evolving landscape.
Highlights include a look into patient perspectives on hidradenitis suppurativa treatment, the potential of rituximab for epidermolysis bullosa acquisita, and an AI-developed educational curriculum for facial neurotoxin injections. You’ll also find valuable data on GLP-1 agonist-related skin reactions, a novel serum for hair appearance improvement, and top dermatologic concerns in patients with skin of color.
Whether you’re focused on medical, aesthetic, or procedural dermatology, the April issue delivers fresh research and forward-thinking strategies to support your practice and patients. Straight from the Editor’s desk, we share this month’s issue highlights:
An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over discusses how this treatment was associated with an excellent level of participant satisfaction and overall local tolerability.
An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris identifies a practical acne treatment and maintenance algorithm integrating acneceuticals with prescription medications and procedures.
The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa assesses 400+ respondents’ perceptions of current and emerging HS treatments and their impact on quality of life.
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature showcases the potential efficacy of rituximab therapy both as a combination therapy and alone as a treatment option for this rare condition.
Single-Center, Open-Label Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum addresses multiple factors involved in the complex pathophysiology of hair loss.
Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1% provides a clinical evaluation of the effects of clascoterone cream 1% on skin barrier function in acne-prone individuals.
Artificial Intelligence-Generated Educational Curriculum on Facial Neurotoxin Injections: Assessment of Educational Content, Curriculum Structure, and Course Logistics aims to assess AI’s ability in developing an educational curriculum for training physician and nurse injectors.
A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies discusses the 5 most common cutaneous reactions associated with GLP-1 agonists.
Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color investigates the most common outpatient dermatologic chief complaints and diagnoses in patients with SOC.
Find more JDD Issue Highlights here.
